With proven capabilities to create public-private partnerships, M2Gen identifies opportunities for ORIEN member institutions to advance the drug development and delivery process by working with industry partners on sponsored projects across the Clinical Trials Continuum, which includes preclinical, in silico trial design, patient-trial matching and cohort surveillance.
A COMMON PROTOCOL
ORIEN member cancer centers are true partners in data exchange and collaboration through the use of a common protocol, Total Cancer Care®.
NATIONAL CLINICAL TRIAL MATCHING SERVICE
M2Gen analyzes data from all participating ORIEN centers to more quickly connect patients with clinical trials based on their molecular profile. ORIEN provides the information and tools needed to study the long-term effects of disease, while assisting cancer center member institutions in their development of precision medicine.
Researchers at ORIEN member institutions access the consortium’s large, shared data warehouse to ask new research questions, develop more effective, competitive, grant submissions and participate in cross-institutional collaborations and biomarker discovery projects with academic partners and pharmaceutical companies. This rapid-learning environment allows scientists to analyze and share findings so that that research can be retested and learnings reapplied.
10902 N. McKinley Drive
Tampa, FL 33612
F (813) 384-5049